Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g

… Pharmaceuticals, Inc. is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, 1g and 3 lots of Ceftriaxone …

Ceftriaxone (marketed as Rocephin) Information

… bottom of this page. Healthcare Professional Information Ceftriaxone (marketed as Rocephin) Prescribing and Labeling … Information … Center for Drug Evaluation and Research … Ceftriaxone (marketed as Rocephin) Information … Ceftriaxone (marketed as Rocephin) Information …

BioMérieux Inc. Recalls VITEK 2 AST Kit due to Incorrect Ceftriaxone Concentrations

… Sensitivity Testing kit, due to a higher concentration of Ceftriaxone antibiotic in 2 wells. This kit is used for … antibiotics. Some of the cards have more of the antibiotic Ceftriaxone in two of their wells than they should. … suggesting they use  an alternate testing method for all Ceftriaxone results. The use of the affected kit may cause …

Ceftriaxone - Injection products

… … Center for Drug Evaluation and Research … Ceftriaxone - Injection products … Drugs … Ceftriaxone - Injection products …

2019 NARMS Update: Integrated Report Summary

… clinical antimicrobial agents is summarized below.  Ceftriaxone As in previous years, ceftriaxone resistance in human isolates remained below 4% in … Infantis in 2014, Heidelberg was one of the more common ceftriaxone-resistant serotypes among human isolates. …

2018 NARMS Update: Integrated Report Summary

… the most important clinical agents is summarized below.  Ceftriaxone Although ceftriaxone resistance in Salmonella from humans remained … in 2018. For most food and animal Salmonella isolates, ceftriaxone resistance declined or remained stable since …

2016-2017 NARMS Integrated Summary

… Market Swine Cecal Sows   2016-2017 Highlights Salmonella Ceftriaxone Ceftriaxone resistance in nontyphoidal Salmonella (henceforth … in 2017. For most food and animal Salmonella isolates, ceftriaxone resistance declined or remained stable at around …

FDA Rationale for Breakpoints Recognition Decision: Azithromycin and Neisseria gonorrhoeae

… that includes an additional antimicrobial agent (i.e., ceftriaxone 250 mg IM single dose). FDA understands that … is monotherapy with a single intramuscular dose of ceftriaxone 500 mg. 2 Reporting and consultation with CDC is … only is the most appropriate for use of azithromycin in ceftriaxone-resistant N. gonorrhoeae . … Center for Drug …

NARMS Interim Data Updates

… typically used to treat infections in humans (e.g., ceftriaxone and ciprofloxacin for treatment of severe … and alternative antimicrobials — ampicillin, azithromycin, ceftriaxone, ciprofloxacin, and … for treatment of salmonellosis — ampicillin, azithromycin, ceftriaxone, ciprofloxacin (including predicted decreased …

Rationale for FDA’s Position on an Azithromycin Susceptible Only Breakpoint for Neisseria gonorrhoeae

… that includes an additional antimicrobial agent (i.e., ceftriaxone 250 mg IM single dose)”. 1 The purpose of the … includes a single dose of intramuscularly administered ceftriaxone 250 mg. Based on the Agency’s evaluation of the … gonococcal infection recommends a single dose of 500 mg ceftriaxone intramuscular injection and no longer recommends …

Heather Tate

… J.R. Plumblee, R.M. Hoekstra, J.M. Whichard, B.E. Mahon. Ceftriaxone-resistant nontyphoidal Salmonella from humans, …

Drug Trials Snapshots: ZEVTERA

… assigned to receive either ZEVTERA (314 subjects) or ceftriaxone with optional linezolid (the comparator; 324 … objective of demonstrating non-inferiority of ZEVTERA to ceftriaxone for the primary endpoint. Table 4. Clinical … 3 (Adult Patients With CABP) Categories ZEVTERA n/N (%) Ceftriaxone ± Linezolid n/N (%) Difference b % (95% CI) c CE …

FDA Releases NARMS Integrated Summary 2019

… to critically important antimicrobial drugs, including ceftriaxone, and shows decreased susceptibility to … is closely monitored because it is sometimes resistant to ceftriaxone and ciprofloxacin, which are antibiotics …

FDA Approves New Antibiotic for Three Different Uses

… least 3 days to receive either Zevtera (314 subjects) or ceftriaxone with optional linezolid [the comparator] (324 …

Antibacterial Susceptibility Test Interpretive Criteria

… No No Ceftolozane and tazobactam Injection Yes Yes Ceftriaxone Injection Yes Yes Cefuroxime axetil Oral Yes No …

Bruce Erickson

… Degrade the Third Generation Cephalosporins Ceftiofur and Ceftriaxone with Multiple β-Lactamases. Wagner R., Johnson …

Table of Pharmacogenomic Biomarkers in Drug Labeling

… Populations, Clinical Pharmacology, Clinical Studies   Ceftriaxone (1) Infectious Diseases G6PD Warnings   Ceftriaxone (2) Infectious Diseases Nonspecific (Congenital …

Cephalosporin Order of Prohibition Questions and Answers

… (for example, third generation cephalosporins such as ceftriaxone) are used in the hospital setting to treat …

2024 Medical Device Recalls

… BioMérieux Inc. Recalls VITEK 2 AST Kit due to Incorrect Ceftriaxone Concentrations Test Recall Confirmed 04/29/2024 …

Doxycycline and Penicillin G Procaine for Inhalational Anthrax (Post-Exposure)

… 209:549-550, 1969. 23. Dattwyler, R. J. et al., "Ceftriaxone compared with doxycycline for the treatment of …

Drug-Induced Liver Injury Severity and Toxicity (DILIst) Dataset

… 1 Oral 549 ceftibuten 0 Oral 550 nitazoxanide 0 Oral 551 ceftriaxone 1 Intravenous 552 cefuroxime 1 Oral 553 …

Drug Induced Liver Injury Rank (DILIrank) Dataset

… 3 Adverse reactions Less-DILI-Concern 2 LT01185 ceftriaxone 4 Adverse reactions Less-DILI-Concern 2 LT01186 …

Antimicrobial Resistance

… 2 AST cards, an AST kit, due to a higher concentration of ceftriaxone antibiotic in two wells. This kit is used for …

Calcium Gluconate Pediatric Safety Review

… neonates who had received simultaneous administration of ceftriaxone and calcium-containing products and the in vitro … studies conducted in neonatal and adult plasma looking for ceftriaxone-calcium precipitates using varying concentrations … • Neonates (28 days of age or younger) receiving ceftriaxone [see Warnings and Precautions (5.2)] 3 Reference …

Summary: NARMS 2012-2013 Integrated Report

… Service, 2014). Physicians rely on antimicrobials such as ceftriaxone and ciprofloxacin for treating patients with … Resistance Extended-spectrum cephalosporins like ceftriaxone are critically important drugs for treating … to one compound results in cross-resistance to the other. Ceftriaxone resistance increased in Salmonella from turkey …